Word: merck
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...from the Rockefeller scientists' research will not be easy, and it certainly will not be quick. Still, this work is "identifying possible targets in the virus, and that's really the exciting part of it," says Dr. Adel Mahmoud, a lecturer at Princeton University and the former head of Merck Vaccines, the company that created the most promising HIV-vaccine candidate to date, which ultimately failed in clinical trials in 2007. (That drug, V520, used a common-cold virus to ferry three synthetic HIV genes into the body to trigger cell-mediated immunity. It was tested in several thousand people...
...There's always been reason to worry about the influence of Big Pharma on the practice of medicine. When doctors are being lavished with meals and speaking fees by the likes of Pfizer and Merck, can you really trust them when they later write prescriptions for those companies' drugs? Medical schools were long considered above such vulgar stuff. Now, however, it turns out that many professors and instructors are, legally, on the dole as well, and students are beginning to worry that what they're being taught is just as one-sided as what patients are being prescribed. Campaigns...
After leaving the Administration, Holder made millions representing corporations like Merck and MBNA. He met Obama six years ago at a Washington dinner party and later advised the then Illinois Senator's office. Obama tapped him, along with Caroline Kennedy, to head his vice-presidential search committee last summer, a process that apparently deepened the candidate's trust in Holder. When Obama called to offer the Attorney General job in late November, the issue of independence arose immediately. Obama made clear he was looking for someone to represent the rule of law, not his political interests, a point Holder stressed...
After 20 years at Harvard Medical School, Professor D. Gary Gilliland will depart to lead cancer research at the pharmaceutical giant, Merck & Co., the company announced earlier this week. While at Harvard, Gilliland gained international recognition for discovering the genetic basis of leukemia and served as director of both the Leukemia Program at the Dana-Farber/Harvard Cancer Center and the Cancer Stem Cell Program for the Harvard Stem Cell Institute. Gilliland’s latest work harnessed his earlier findings to explore how drugs could be used to treat leukemia. “His expertise in both basic...
...seek out overly expensive brand-name drugs from doctors. Their symptoms might not require such medications, and when they do, cheaper generic drugs may be available. Such marketing probably drives up overall health-care costs. More important, new drugs that are aggressively marketed can pose a safety risk. Merck's heavy promotion of pain reliever Vioxx - look at Dorothy Hamill skating without any strain! - is a prime example of advertising gone awry. The drug was later taken off the market after it was found to increase risk for heart attacks...